Patent Assignment
Reel/Frame 017303/0157
Change of Name
Recorded: 2006-03-01
Pages: 4
Assignor
GENETICS INSTITUTE, INC.
Executed: 2001-12-28
Assignee
GENETICS INSTITUTE, LLC
87 CAMBRIDGE PARK DRIVE, CAMBRIDGE, MASSACHUSETTS, 02140
Covered Properties
(3)
B7-2: a CTLA4/CD28 Ligand
Patent:
5,942,607 →
Application:
08/101,624 →
Antibodies Against CTLA4
Methods of Modulating An Immune Response With Antibodies Against CTLA4
Application:
11/321,444 →
Publication:
US 2006/0165706
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 10, 2006
From: PROTEIN DESIGN LABS, INC.
To: GENETICS INSTITUTE, INC.
Reel/Frame 017175/0625 →
Confirmatory License
Jul 14, 2008
From: DANA-FARBER CANCER INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021234/0486 →
Confirmatory License
May 29, 2011
From: DANA-FARBER CANCER INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 026358/0169 →